AstraZeneca Plc said it chose Ireland for a new manufacturing facility instead of the UK because of punitive tax rates, raising fresh fears over Britain’s attractiveness to Big Pharma.
The drugmaker initially wanted to make the $360 million investment in the UK, but “the tax rate was discouraging,” Chief Executive Officer Pascal Soriot said in a briefing with journalists. “You need an environment that gives you good returns and incentive to invest.”
Canada Canada Latest News, Canada Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: businessposthq - 🏆 8. / 71 Read more »
Source: IrishTimes - 🏆 3. / 98 Read more »